PATENT CLAIM ANALYSIS

Application Number: 15757267
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "181000"]

Abstract:
The present invention relates to methods for the diagnosis or prognosis of conditions caused by defects in cholesterol biosynthesis, such as Smith-Lemli-Opitz syndrome (SLOS), in particular to early diagnostic methods including in utero methods. In one aspect, the method compries detecting in a biological sample levels of delta-5 bile acid conjugated with 2-(acetylamino)-2-deoxy-D-glucose (GlcNAc) of formula (I)

Claim (Index 15):
A method according to  claim 14  wherein the conjugation agent is a Girard agent

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.31481
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14770313', '14425548', '10949490', '13406092', '14976177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7262200063372762
- 35 USC 102 Novelty (BERT): 0.5364329179149687
- Combined Prediction Score: 0.7072412974950455
- Mean Citation Score: 241.891188
- Max Citation Score: 307.12875
- Similarity Product: 158.68406132072215

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test